VIATRIS INC. Disposal Group, Including Discontinued Operation, Revenue
VIATRIS INC. (VTRS) reported Disposal Group, Including Discontinued Operation, Revenue of $185.30 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2022-11-07
- VIATRIS INC. disposal group, including discontinued operation, revenue for the quarter ending 2022-09-30 was $185.30M.
- VIATRIS INC. disposal group, including discontinued operation, revenue for the quarter ending 2022-06-30 was $166.90M.
- VIATRIS INC. disposal group, including discontinued operation, revenue for the quarter ending 2022-03-31 was $169.10M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month |
|---|---|---|---|
| 2022-09-30 | $185.30M 10-Q · filed 2022-11-07 | $352.20M derived: sum of 2 quarters · filed 2022-11-07 | $521.30M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $166.90M 10-Q · filed 2022-08-08 | $336.00M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $169.10M 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |